Duct stenting in an ELBW infant with aortic arch interruption

Andriana S Anagnostopoulou1, Evangelos S Karanasios1, Nicholaos G Eleftherakis1

  • 1Department of Cardiology, Aghia Sophia Children's Hospital, Athens, Greece.

Insights

Aortic arch interruption is a rare congenital heart defect. Ductal stenting offers a promising alternative treatment for affected infants, improving survival rates.

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Neonatology

Background:

  • Aortic arch interruption is a rare congenital heart malformation.
  • It can be associated with complex congenital heart disease.
  • Survival in extremely low birth weight infants with this condition is exceptionally rare.

Observation:

  • Extremely low birth weight infants present unique challenges for cardiac care.
  • Congenital heart defects require timely and appropriate interventions.
  • Surgical correction is the definitive treatment for aortic arch interruption.

Findings:

  • Ductal stenting serves as a viable bridge procedure for small infants with aortic arch interruption.
  • This approach can stabilize infants prior to definitive surgical correction.
  • It offers a potentially life-saving alternative in critical neonatal cases.

Implications:

  • Ductal stenting expands treatment options for neonates with complex cardiac conditions.
  • Early intervention strategies can improve outcomes for extremely low birth weight infants.
  • Further research into minimally invasive techniques is warranted for congenital heart disease management.

Related Concept Videos